Israeli AI-driven healthcare provider Aidoc, announced last week it has received FDA 510(k) clearance for its newly developed X-ray solution that detects cases of pneumothorax (collapsed lung) on X-rays for more efficient triage.
Pneumothorax is a condition known to worsen at a rapid pace leading to respiratory or cardiac failures that oftentimes can not be avoided in time due to the extensive imaging and examinations that radiologists are required to administer.
Aidoc’s FDA-approved solution addresses this issue by applying a highly accurate algorithm to analyze X-ray images, which can then flag early indicators of pneumothorax for radiologists so that physicians can initiate treatment protocols much sooner. Its AI platform scans and processes high volumes of images without disrupting workflow and does not require any additional infrastructure or maintenance efforts.
The software can run on all X-rays, including portable machines, and flag positives cases of pneumothorax so physicians can focus on the images quickly, Aidoc said.
“We’re very excited about this important milestone,” said Elad Walach, CEO of Aidoc. “This FDA clearance further validates the breadth of our AI platform, going beyond specific AI algorithms to act as a healthcare AI hub for the enterprise’s cross-specialty needs. This includes ER, ICU, outpatient centers, inpatient admissions, and the coordination of care and communication among providers.”
Founded in 2016, Aidoc has developed software that analyzes medical images. This software ultimately helps to expedite treatment procedures and reduce patient turnaround time. It has analyzed over 8 million cases to date.
Aidoc’s seven other FDA-cleared solutions are already implemented across US health systems, They include solutions for triaging and detection of incidental pulmonary embolism, triaging cervical spine fractures, and flagging acute intracranial hemorrhage.
“By bringing radiologists and proceduralists to the same AI platform, we enable enhanced collaboration across departments and systems to deliver patients with the right treatment at the right time,” Walach added.
Facebook comments